Valuation: Guerbet

Market Cap 84.27M 94.46M 78.51M 71.45M 135M 9.1B 136M 949M 369M 4.64B 355M 347M 14.92B P/E 2026 *
-3.74x
P/E 2027 * 7.27x
Enterprise Value 460M 515M 428M 390M 734M 49.65B 740M 5.18B 2.01B 25.34B 1.94B 1.89B 81.45B EV / Sales 2026 *
0.6x
EV / Sales 2027 * 0.57x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.49%
1 day-0.45%
1 week-5.67%
Current month-5.00%
1 month-11.92%
3 months-24.52%
6 months-24.09%
Current year-53.50%
1 week 6.6
Extreme 6.6
7.05
1 month 6.6
Extreme 6.6
7.56
Current year 6.6
Extreme 6.6
15.12
1 year 6.6
Extreme 6.6
18.26
3 years 6.6
Extreme 6.6
40.25
5 years 6.6
Extreme 6.6
44.4
10 years 6.6
Extreme 6.6
90.64
Manager TitleAgeSince
Chief Executive Officer - 02/02/2026
Chief Executive Officer - 22/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 29/05/2015
Director/Board Member 50 19/05/2017
Director/Board Member 52 22/11/2023
Date Insider Type Main position Quantity % Market Cap. Importance
6/8/26 Buy

Director

1,185 0.0094%
5/8/26 Buy

Director

5,027 0.0398%
4/8/26 Buy

Director

3,788 0.0300%
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%-5.67%-52.02%-58.33% 94.84M
+2.51%-1.09%+23.40%+34.78% 242B
+3.18%-2.91%+4.25%+1.77% 150B
+3.61%-2.22%-9.81%+39.81% 138B
-0.22%-3.60%-56.03%-17.72% 61.74B
+2.51%+0.67%+14.17%+21.07% 49.08B
-1.08%-3.15%-22.50%-21.55% 47.43B
+1.89%-2.54%+20.58%+54.74% 47.3B
+2.17%-0.49%-7.06%+38.33% 44.25B
+2.86%-1.20%+33.57%+64.52% 41.78B
Average +1.71%-2.75%-5.14%+15.74% 82.27B
Weighted average by Cap. +2.38%-2.98%+3.86%+24.42%

Financials

2026 *2027 *
Net sales 764M 856M 712M 648M 1.22B 82.46B 1.23B 8.6B 3.35B 42.09B 3.21B 3.14B 135B 798M 895M 744M 677M 1.27B 86.17B 1.28B 8.99B 3.5B 43.98B 3.36B 3.29B 141B
Net income -35.8M -40.13M -33.35M -30.35M -57.16M -3.86B -57.58M -403M -157M -1.97B -151M -147M -6.34B 8.3M 9.3M 7.73M 7.04M 13.25M 896M 13.35M 93.44M 36.35M 457M 34.93M 34.17M 1.47B
Net Debt 376M 421M 350M 318M 600M 40.55B 604M 4.23B 1.65B 20.7B 1.58B 1.55B 66.52B 370M 415M 345M 314M 591M 39.98B 596M 4.17B 1.62B 20.4B 1.56B 1.52B 65.59B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
05/10/26 €6.650 -0.45% 6,660
02/10/26 €6.680 -0.45% 25,636
01/10/26 €6.710 -4.14% 31,443
30/09/26 €7.000 +0.29% 5,131
29/09/26 €6.980 -0.99% 22,057
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
6.680EUR
Average target price
8.433EUR
Spread / Average Target
+26.25%

Quarterly revenue - Rate of surprise